new_0222_0624|SGTX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0624|SGTX|1|Sigilon Therapeutics Inc Total Current Assets (Quarterly) (USD)|Sigilon Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Sigilon Therapeutics Inc Inventories (Quarterly) (USD)|Sigilon Therapeutics Inc Net PP&E (Quarterly) (USD)|Sigilon Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Sigilon Therapeutics Inc Total Liabilities (Quarterly) (USD)|Sigilon Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Sigilon Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Sigilon Therapeutics Inc Total Deposits (Quarterly) (USD)|Sigilon Therapeutics Inc Book Value (Quarterly) (USD)|Sigilon Therapeutics Inc Retained Earnings (Quarterly) (USD)|Sigilon Therapeutics Inc Treasury Stock (Quarterly) (USD)|Sigilon Therapeutics Inc EV to Revenues|Sigilon Therapeutics Inc EV to Earnings|Sigilon Therapeutics Inc EV to Free Cash Flow|Sigilon Therapeutics Inc EV to Assets (Quarterly)|Sigilon Therapeutics Inc PS Ratio|Sigilon Therapeutics Inc PE Ratio|Sigilon Therapeutics Inc Price to Book Value|Sigilon Therapeutics Inc PEG Ratio|Sigilon Therapeutics Inc Debt to Equity Ratio|Sigilon Therapeutics Inc Dividend Yield|Sigilon Therapeutics Inc Shareholder Yield (TTM)|Sigilon Therapeutics Inc Percent of Shares Outstanding Short|Sigilon Therapeutics Inc Total Receivables (Quarterly) (USD)|Sigilon Therapeutics Inc Total Payables (Quarterly) (USD)|Sigilon Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Sigilon Therapeutics Inc Return on Invested Capital|Sigilon Therapeutics Inc Quality Ratio Score|Sigilon Therapeutics Inc Momentum Score|Sigilon Therapeutics Inc Beta (1Y)|Sigilon Therapeutics Inc Sustainable Growth Rate (TTM)|Sigilon Therapeutics Inc Institutional Investor Ownership Percentage|Sigilon Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Sigilon Therapeutics Inc Total Employees (Annual)|Sigilon Therapeutics Inc EPS Diluted (Quarterly) (USD)|Sigilon Therapeutics Inc SG&A Expense (Quarterly) (USD)|Sigilon Therapeutics Inc Shares Outstanding|Sigilon Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Sigilon Therapeutics Inc Ordinary Shares Number (Quarterly)|Sigilon Therapeutics Inc Payout Ratio|Sigilon Therapeutics Inc Quick Ratio (Quarterly)|Sigilon Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Sigilon Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Sigilon Therapeutics Inc Effective Tax Rate (TTM)|Sigilon Therapeutics Inc Return on Equity|Sigilon Therapeutics Inc Net Income (TTM) (USD)|Sigilon Therapeutics Inc Revenue (TTM) (USD)|Sigilon Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Sigilon Therapeutics Inc Revenue (Quarterly) (USD)|Sigilon Therapeutics Inc Gross Profit (Quarterly) (USD)|Sigilon Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Sigilon Therapeutics Inc Net Income (Quarterly) (USD)|Sigilon Therapeutics Inc Net Interest Income (Quarterly) (USD)|Sigilon Therapeutics Inc Price (USD)|Sigilon Therapeutics Inc Total Return Price (USD)|Sigilon Therapeutics Inc Enterprise Value (USD)|Sigilon Therapeutics Inc 30-Day Average Daily Volume|Sigilon Therapeutics Inc 1 Year Price Returns (Daily)|Sigilon Therapeutics Inc Short Interest|Sigilon Therapeutics Inc PE Ratio (Forward)|Sigilon Therapeutics Inc PE Ratio (Forward 1y)|Sigilon Therapeutics Inc PS Ratio (Forward)|Sigilon Therapeutics Inc PS Ratio (Forward 1y)|Sigilon Therapeutics Inc Quarterly EPS Estimates (USD)|Sigilon Therapeutics Inc Quarterly Revenue Estimates (USD)|Sigilon Therapeutics Inc Quarterly EPS Surprise|Sigilon Therapeutics Inc Quarterly Revenue Surprise|Sigilon Therapeutics Inc Quarterly Actual EPS (USD)|Sigilon Therapeutics Inc Quarterly Actual Revenue (USD)|Sigilon Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Sigilon Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Sigilon Therapeutics Inc Price Target (USD)|Sigilon Therapeutics Inc Consensus Recommendation|Sigilon Therapeutics Inc Price Target Num Estimates|Sigilon Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Sigilon Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Sigilon Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Sigilon Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Sigilon Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Sigilon Therapeutics Inc Land and Improvements (Quarterly) (USD)|Sigilon Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Sigilon Therapeutics Inc Other Properties (Quarterly) (USD)|Sigilon Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0624|SGTX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0624|SGTX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0624|SGTX|5|127.8|127.8||127.8||127.8|127.8|127.8||127.8|127.8||1.45065789474|91|1.44755244755|91|1.45065789474||1.45065789474|1.4387755102|91.2857142857|1.45065789474||15.2592592593|127.8|127.8|127.8|91|||31|91|30.4615384615|91.2857142857|182.5|91.2857142857|91.2857142857|30.5454545455||127.8|91.25|91.2857142857|91.2857142857|||91|91.25|91.25||91.2857142857||91.2857142857|91.2857142857|91.2857142857|1.45065789474|1.45065789474|1.45065789474|1.43636363636|1.42307692308|15.2592592593|||1.44755244755|1.44755244755|91.25|91.25|91|91|91|91|20.45|31.4615384615|18.5909090909|12.3939393939|18.5909090909|21.4210526316|25.5625|91.2857142857|91.2857142857|91.2857142857|||127.8|127.8||
new_0222_0624|SGTX|6|5|5||5||5|5|5||5|5||304|3|286|3|304||304|98|7|304||27|5|5|5|3|||1|3|13|7|2|7|7|11||5|4|7|7|||3|4|4||7||7|7|7|304|304|304|275|52|27|||286|286|8|8|3|3|3|3|20|13|22|33|22|19|16|7|7|7|||5|5||
new_0222_0624|SGTX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0624|SGTX|201912|76.937|76.069||12.8||168.14|40.375|127.765||-77.762|-81.32||||||||||-0.1912||||0.136|2.005|0.005|||||||21.043||-0.6207|2.9|||28.7903||1.8874|-0.6999|||||||3.098||-14.729|-14.729|0.089||||||||||||||||||||||||15.014|0.188|0.188|||13.553|0.39||
new_0222_0624|SGTX|202003||||||||||||||||||||||||||||||||||21.043||-0.6052|2.871||||||-0.6035|||||||3.466||-12.735|-12.735|-0.005||||||||||||||||||||||||13.274|0.202|0.208||||||
new_0222_0624|SGTX|202006||||||||||||||||||||||||||||||||||21.043||-0.6411|2.818||||||-0.6411|||||||1.951||-13.49|-13.49|-0.161||||||||||||||||||||||||12.452|0.208|0.196||||||
new_0222_0624|SGTX|202009|63.7|62.642||11.551||74.778|45.328|29.45||2.675|-120.739||||||||||7.3794||||0.067|0.671|0.021|||||||28.7903|96|-0.4583|3.334|28.7903||28.7903||1.3834|-0.446||||-54.148|12.716||4.201||-13.194|-13.194|-0.263||||||||||||||||||||||||13.425|0.218|0.293|||12.92|0.4||
new_0222_0624|SGTX|202012|204.21|202.229||19.722||78.894|47.018|31.876||146.156|-135.928||99.3601|-24.3342|-21.2207|5.9047|91.8844||10.3401||0.1355|||0.1627|0.177|1.988|0.031|-130.5537||||-230.514|69.8867|31.465|99|-1.15|3.505|31.465||31.465||4.3049|-1.1309|||-230.514|-54.608|13.374||3.756||-15.189|-15.189|-0.461|48.03|48.03|1328.842|110317.8||51180|||136.1223|96.1058|-1.785|3.2|38.2241|17.375|-1.1027|3.756|12.5333|12.4|51|2|3|-4.75|-2.14|14.337|0.226|0.505|||21.056|0.65|30.61|26.6
new_0222_0624|SGTX|202103|183.062|178.789||19.205||74.353|34.479|39.874||129.032|-154.901||42.3717|-8.9596|-7.7667|2.6804|48.9812||5.4566||0.154|||1.8127|0.14|2.006|0.032|-54.12||||-121.6306|77.6322|31.4877||-0.6|5.54|31.502||31.502||5.1895|-0.6|||-121.6306|-60.846|12.866||2.958||-18.973|-18.973|-0.402|22.35|22.35|545.1547|169459.3333||571027|||63.4168|44.7739|-0.56|3.5|-7.1429|-15.4857|-0.6|2.958|13.2667|17.2|50.25|1.75|4|-2.57|-2.67|15.985|0.247|0.488|||20.768|0.668|13.9|11.67
new_0222_0624|SGTX|202106|166.27|162.406||18.558||75.054|44.386|30.668||111.067|-175.338||14.6439|-2.9418|-2.8284|1.0715|24.289||3.0783||0.1795|||2.0118|0.178|4.661|0.032|-57.9066||||-108.9331|80.4951|31.5717||-0.65|4.992|31.864||31.864||3.663|-0.65|||-108.9331|-67.793|13.619||2.704||-20.437|-20.437|-0.423|10.73|10.73|199.4357|254381.1667||641029|||30.7956|21.7425|-0.66|3.1|1.5152|-12.7742|-0.65|2.704|11.7333|16.9667|28.75|1.75|4|-2.7|-2.65|17.751|0.263|0.494|||20.336|0.716|5.04|5.94
new_0222_0624|SGTX|202109|144.026|140.393||18.478||70.493|40.866|29.627||93.304|-195.494||5.416|-0.8234|-0.7677|0.3758|15.732||1.9499|-0.0615|0.2144|||2.4142|0.027|3.226|0.032|-64.2661||||-77.5091|73.5584|32.0556|115|-0.63|5.041|32.2013||32.2013||3.4361|-0.63|||-77.5091|-74.755|11.365||1.947||-20.156|-20.156|-0.443|5.65|5.65|61.5533|214518.5333||777389|||16.3874|11.5699|-0.68|2.9|7.3529|-32.8621|-0.63|1.947|11.6405|15.725|19.4|1.75|5|-2.665|-2.38|16.645|0.306|0.499|||20.508|0.752|5.39|3.76
new_0222_0624|SGTX|202112|||||||||||||-2.7462||0.3893||7.685||0.9557|-0.0301||||0.7224||||||1|0.143||72.8404||||||||||||||||||||||2.76|2.76|-31.2103|189632.5333|-94.2536|233399|||6.3244|7.153|-0.53|2.6667|||||10.7272|14.1|7.15|2|5|-2.2375|-1.5725||||||||1.95|1.48
new_0222_0624|SGTX|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.34|3.2||||||||||||||||||||
new_0222_0624|SGTX|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.36|3.2||||||||||||||||||||
new_0222_0624|SGTX|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.385|3.2||||||||||||||||||||
new_0222_0624|SGTX|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.41|3.2||||||||||||||||||||